المؤلفون: Steubl, Dominik, Buzkova, Petra, Garimella, Pranav S, Ix, Joachim H, Devarajan, Prasad, Bennett, Michael R, Chaves, Paolo HM, Shlipak, Michael G, Bansal, Nisha, Sarnak, Mark J

المصدر: American Journal of Kidney Diseases. 74(4)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Aging, Clinical Research, Cardiovascular, Kidney Disease, Prevention, Renal and urogenital, Good Health and Well Being, Aged, Aged, 80 and over, Biomarkers, Cardiovascular Diseases, Cohort Studies, Female, Glomerular Filtration Rate, Humans, Kidney, Kidney Failure, Chronic, Kidney Function Tests, Male, Random Allocation, Uromodulin, Tamm-Horsfall-protein, cardiovascular disease, chronic kidney disease, end-stage renal disease, estimated glomerular filtration, kidney function decline, mortality, renal end point, sUMOD, tubular function, Public Health and Health Services, Urology & Nephrology, Clinical sciences

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/7mr3f1dr

المؤلفون: YANG Jiangxin, XIONG Jiachuan, YANG Ke, ZHAO Jinghong

المصدر: Di-san junyi daxue xuebao, Vol 42, Iss 2, Pp 154-161 (2020)

مصطلحات موضوعية: chronic kidney disease, klotho protein, renal end point events, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: http://aammt.tmmu.edu.cn/Upload/rhtml/201908129.htm; https://doaj.org/toc/1000-5404

URL الوصول: https://doaj.org/article/f7768982fcfd409ea777d533777eaf42

المؤلفون: Lesley A. Inker, Josef Coresh, Hiddo J.L. Heerspink, Hasi Mondal, Shoshana H. Ballew, Yingying Sang, Hocine Tighiouart, Kunihiro Matsushita, Andrew S. Levey

المساهمون: Groningen Kidney Center (GKC), Methods in Medicines evaluation & Outcomes research (M2O)

المصدر: American Journal of Kidney Diseases, 64(6), 860-866. W B SAUNDERS CO-ELSEVIER INC

مصطلحات موضوعية: medicine.medical_specialty, NEPHROPATHY, Renal function, chronic kidney disease (CKD), GLOMERULAR-FILTRATION-RATE, Nephropathy, law.invention, kidney end point, Randomized controlled trial, law, Risk Factors, Internal medicine, medicine, EQUATION, Humans, Renal Insufficiency, Chronic, Intensive care medicine, kidney disease outcome, BLOOD-PRESSURE CONTROL, renal end point, estimated glomerular filtration rate (eGFR) decline, Randomized Controlled Trials as Topic, surrogate end point, business.industry, Surrogate endpoint, kidney disease progression, renal function, DISEASE PROGRESSION, medicine.disease, Clinical trial, meta-analysis, RENAL-DISEASE, Treatment Outcome, Nephrology, end-stage renal disease (ESRD), Meta-analysis, Observational study, business, Kidney disease, Glomerular Filtration Rate

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1203de31aeff6b35953646be84e93ea6
https://doi.org/10.1053/j.ajkd.2014.08.018

المؤلفون: Lesley A. Inker, Hiddo J.L. Heerspink, Andrew S. Levey, Christopher H. Schmid, Hocine Tighiouart, Farzad Noubary, Tom Greene, Josef Coresh, Hasi Mondal

المساهمون: Groningen Kidney Center (GKC), Methods in Medicines evaluation & Outcomes research (M2O)

المصدر: American Journal of Kidney Diseases, 64(6), 848-859. W B SAUNDERS CO-ELSEVIER INC

مصطلحات موضوعية: IDIOPATHIC MEMBRANOUS NEPHROPATHY, IGA NEPHROPATHY, medicine.medical_specialty, treatment effect, Endpoint Determination, LONG-TERM, Population, Renal function, METHYLPREDNISOLONE PLUS CHLORAMBUCIL, chronic kidney disease (CKD), GLOMERULAR-FILTRATION-RATE, law.invention, eGFR trajectory, Randomized controlled trial, law, Internal medicine, medicine, Credible interval, Humans, CONVERTING ENZYME-INHIBITION, Intensive care medicine, education, kidney disease outcome, BLOOD-PRESSURE CONTROL, renal end point, MYCOPHENOLATE-MOFETIL, estimated glomerular filtration rate (eGFR) decline, Randomized Controlled Trials as Topic, surrogate end point, education.field_of_study, business.industry, Surrogate endpoint, kidney disease progression, renal function, medicine.disease, LUPUS NEPHRITIS, Clinical trial, Treatment Outcome, Nephrology, end-stage renal disease (ESRD), Meta-analysis, Kidney end point, Kidney Failure, Chronic, CHRONIC-RENAL-FAILURE, business, Kidney disease, Glomerular Filtration Rate

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf596761f3f55d8fb5d61106578f43d0
https://doi.org/10.1053/j.ajkd.2014.08.017

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Dick de Zeeuw, Edmund J. Lewis, Andrew S. Levey, Kunihiro Matsushita, Kerry Willis, Tom Greene, Alfred K. Cheung, Josef Coresh, Lesley A. Inker

المساهمون: Groningen Kidney Center (GKC)

المصدر: American Journal of Kidney Diseases, 64(6), 821-835. W B SAUNDERS CO-ELSEVIER INC

مصطلحات موضوعية: medicine.medical_specialty, Endpoint Determination, Psychological intervention, Renal function, BLOOD-PRESSURE, chronic kidney disease (CKD), ALL-CAUSE, urologic and male genital diseases, GLOMERULAR-FILTRATION-RATE, Education, eGFR trajectory, medicine, Humans, Renal Insufficiency, Chronic, Intensive care medicine, kidney disease outcome, renal end point, estimated glomerular filtration rate (eGFR) decline, surrogate end point, Clinical Trials as Topic, SERUM CREATININE, business.industry, Surrogate endpoint, United States Food and Drug Administration, urogenital system, kidney disease progression, MORTALITY, renal function, STAGE RENAL-DISEASE, medicine.disease, United States, RISK POPULATION COHORTS, Clinical trial, Blood pressure, Nephrology, Sample size determination, end-stage renal disease (ESRD), ANTIHYPERTENSIVE THERAPY, Kidney end point, COLLABORATIVE METAANALYSIS, Biomarker (medicine), biomarker, business, HIGHER ALBUMINURIA, Kidney disease, Foundations, Glomerular Filtration Rate

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fd303dd3bf1e501be937378845a5854
https://research.rug.nl/en/publications/93904ccf-e1f9-4313-9e90-9fa1d22b5235

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.